Immortalized Cell Line Market Overview
Immortalized cell lines have wide application in the field of healthcare and life science. Increasing adoption of cell line system in cancer therapy, increasing research and development activities and growth in biotechnology sector drive the global immortalized cell line market size. The global immortalized cell line market is expected to grow at a CAGR of 9.30% is anticipated to reach USD 4,105.62 million during 2017-2023.
Demand for organ transplant has been on the rise but there is a scarcity in the availability of organs. For instance, according to the American Transplant Foundation, as of 2019, nearly 114,000 people are waiting on the organ transplant list in the U.S. alone and nearly 20 people die every day due to the lack of viable organs. Researchers have therefore been working to develop artificial biological cells which would in turn drive the immortalized cell line market.
Moreover, the rising incidence of cancer and urgent need to find effective treatment for the various types of cancer, are factors that will potentially boost the immortalized cell line market. Researchers and scientists often study the cells from an extracted tumor to understand what are the conditions that are triggering the growth of cancerous cells and develop means through which it can be ascertained how much cancer is in the body and predict how the cancer will behave and in what way it will respond to treatment.
The high cost of equipment and difficulty in stable cell line development can prove to be some of the obstacles in the growth path of immortalized cell line market but increased financial support provided by government and private entities would be suffice to overcome such hurdles and lead to future industry growth.
Immortalized Cell Line Market Segmentation:
The immortalized cell line market has been segmented according to method, application, and end user.
According to method, immortalized cell line market is classified into virus hTERT expression, induction, inactivation of tumor suppression genes, and others.
By application, immortalized cell line market, is divided into drug discovery, diagnostics, tissue engineering and regenerative medicine, vaccine production, and others.
End user segmentation of immortalized cell line market includes Contract Research Organizations (CROs), pharmaceutical and biopharmaceutical companies, and research laboratories. The pharmaceutical and biopharmaceutical companies segment amassed a revenue of approximately USD 1,323.79 million in 2017.
Immortalized Cell Line Market Regional Analysis:
Regional segmentation of immortalized cell line market has been done on the basis of Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is expected to hold a dominating position in the global immortalized cell line market owing to the presence of well-established pharmaceutical and biotechnology industry in the region as well as greater incidence of cancer, expansive research funding and increasing awareness about immortalized cell lines.
Europe immortalized cell line market size is anticipated to be second to that of the Americas during the forecast period. Robust government support, technology advancements in healthcare, and rising incidence of cancer would boost market growth in the region.
Asia-Pacific immortalized cell line market is anticipated to record fastest-growth due to the increasing expenditure by governments on enhancement of healthcare facilities. Expanding research for betterment of healthcare offerings and expansive patient population have attracted key players to shift their focus to the region which has helped Asia Pacific to register a market share of 17.8% in 2017.
Immortalized Cell Line Market Competitive Overview:
Some of the prominent players in the immortalized cell line market include Thermo Fisher Scientific, American Type Culture Collection Inc., Valneva, Sartorius AG, Lonza Group, AG, Merck KGaA (Germany), Selexis SA, WuXi App Tec, European Collection of Authenticated Cell Cultures, and Corning Incorporated.
Immortalized Cell Line Industry News:
Immortalized cell line market will witness expansion owing to the varied application of the process in development of novel therapeutics for diseases ranging from cancer to malaria. For instance, researchers at the Imperial College London and University of Bristol have established a system that utilizes lab grown red blood cells to study the mechanism that is adopted by malaria parasites to invade red blood cells.
The work, which is aimed at facilitating understanding and disruption of the mechanism of red blood cell invasion by malaria parasites, is funded by NHS Blood and Transplant and the National Institute for Health Research.
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/immortalized-cell-line-market-751
Plasmodium falciparum is the malaria parasite that infects nearly 200 million people and causes half a million deaths each year around the world. For the experiment, researchers have used immortalized cell line technology to produce unlimited numbers of immature 'progenitor cells' that can be manipulated to produce new red blood cells (reticulocytes) in the lab. The researchers were able to show that cells produced in the technique could support both invasion by and intracellular development of Plasmodium falciparum.
Immortalized cell lines are tumorous cells which undergo multiplication or have been artificially created to be cultured continuously over generations.
The global immortalized cell line market report by Market Research Future (MRFR) contains useful insights, segmental analysis, and profiles of key industry leaders as well as their strategies for the period between 2017 and 2023.Immortalized Cell Line Market OverviewThe global immortalized cell line market is slated to display a CAGR of 9.3% from 2017 to 2023 (forecast period) to touch a valuation of USD 4,105.62 million by 2023.
Large application of cell lines in pharmaceutical and biopharmaceutical sectors are expected to drive market growth.
Management of cell lines can ensure the success of future experiments and expedite research and development.Development of novel drugs are likely to spur the global immortalized cell line market growth.
For instance, Onconeutics received approval for the use of ONC201 by the U.S. Food and Drug Administration (FDA) in 2018 for the treatment of abnormal malignant growths.
It has been run on cell lines of various types of cancers with a degree of success and will be used in targeted therapies in the near future.But prevention of infections on cell strains and high costs of equipment can act as restraints against market growth.Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/751Immortalized Cell Line Market SegmentationThe global immortalized cell line market has been segmented into method, application, and end user.Based on the method, the global market has been segmented into virus induction, hTERT expression, inactivation of tumor suppression genes, and others.
We conduct an accurate and reliable COVID Test.
Our qualified phlebotomists trained for safe and hygienic sample collecting during Test for COVID 19.
We are the most trustworthy lab for COVID 19 testing in India.
Get your COVID-19 Test done with Metropolis Healthcare.
The whole globe has experienced the adverse effect of coronavirus and every industry has faced setbacks especially the real estate industry.
Market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine.
In addition, high growth is expected for plastic surgery and wound healing applications, which will further drive the growth of the biomaterials market in the coming years.
[298 Pages Report] The global biomaterials market size is projected to reach USD 47.5 billion by 2025 from USD 35.5 billion in 2020, at a CAGR of 6.0% during the forecast period.This study involved four major activities in estimating the current size of the biomaterials market.
Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.
The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Market DynamicsIncreased funds and grants by government bodies and universities for the development of novel biomaterials Increasing demand for implantable devices Growing demand for biomaterials in plastic surgery and wound healing applicationsRising incidence of cardiovascular diseasesIncreasing research on regenerative medicineCOVID-19 impact on the biomaterials marketCOVID-19 is an infectious disease caused by the most recently discovered novel coronavirus.
With the World Health Organization (WHO) officially declaring the outbreak of COVID-19 a pandemic, a mix of established pharmaceutical and biopharmaceutical companies, as well as small startups, have stepped forward to develop treatments and vaccines that target the infection caused by the novel coronavirus.The coronavirus outbreak disrupted business and economic activities globally in the first quarter of 2020.
The report "Covid-19 Impact On Cybersecurity Market by Technology (Network Security, Application Security, Endpoint Security, Cloud Security, Database Security, Web Security, ICS Security), Vertical, Region - Global Forecast to 2021", size is expected to grow from USD 183.2 billion in 2019 to USD 230.0 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 12.0% during the forecast period.
The market growth can be attributed to increasing focus on cybersecurity-driven business continuity plans to provide optimized security to customer data and operations that are being handled by the companies.
Increasing focus on cybersecurity as a critical business imperative and not just as a support function is expected to further drive the market with a higher wallet share for security policies and infrastructure.Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=128702677Manufacturing vertical to see less growth during the forecast period in the cybersecurity marketAs the COVID-19 crisis continues to expand, manufacturers would likely face challenges on numerous fronts.
Manufacturing companies would be looking for immediate measures to keep their workforces safe and their businesses solvent.
As the COVID-19 pandemic intensifies, manufacturers would likely face continued downward pressure on demand, production, and revenues.
They would also face cash-flow liquidity challenges and difficulties in managing debt obligations.China is the manufacturing hub for almost all raw material requirements across the globe; the COVID-19 pandemic has affected the global economy and disrupted supply chains.
